United Press International - October 19, 2009
U.S. researchers recommend quickly treating maternal human immunodeficiency virus to prevent transmitting the virus to newborns.
The study, published online in ahead of print in the Nov. 15 issue of The Journal of Infectious Disease, finds 82 percent of the mothers in the African country of Malawi involved in the study who received highly active anti-retroviral therapy did not infect their newborns with HIV through breastfeeding.
The study, led by Taha E. Taha of Baltimore's Johns Hopkins University Bloomberg School of Public Health, involved 2,318 infant/mother pairs. A total of 130 infants -- about 6 percent -- became HIV-1-infected. The transmission rate for the virus was 1.8 percent in treatment-eligible mothers who received treatment versus a rate of 10.6 percent in treatment-eligible mothers who did not receive treatment.
The researchers say the choices are unclear for HIV-infected women who do not need highly active anti-retroviral therapy for their own health. This was the case of about 70 percent of the Malawi patients in the study.
Their rate of transmission was 3.7 percent. The researchers say options include prolonged infant anti-viral prophylaxis beyond 14 weeks of age or the institution of highly active anti-retroviral therapy in mothers not requiring therapy according to current guidelines.
091019
UP091005
Copyright © 2009 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .